Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 2/20 | 0.61 |
| ▸ | CES1 | P23141 | 5/20 | 0.56 |
| ▸ | NSD2 | O96028 | 1/20 | 0.56 |
| ▸ | BCHE | P06276 | 1/20 | 0.56 |
| ▸ | LIG1 | P18858 | 1/20 | 0.51 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | CASP2 | P42575 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | CASP6 | P55212 | 1/20 | 0.45 |
| ▸ | CASP8 | Q14790 | 1/20 | 0.45 |
| ▸ | MAOA | P21397 | 1/20 | 0.44 |
| ▸ | MAOB | P27338 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5329335 | 0.87 | DAO (0.56) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL9686821 | 0.83 | DAO (0.51) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL10648890 | 0.83 | CES1 (0.55) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL20303987 | 0.83 | CES1 (0.55) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL3088689 | 0.76 | DAO (1.00) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL24673381 | 0.76 | CASP3 (0.51) | DAOPDK2CASP3CASP2CASP7 | |
| SCHEMBL5329295 | 0.75 | DAO (0.54) | DAOCES1NSD2BCHELIG1 | |
| Hydrochloric Acid SCHEMBL11430657 | 0.74 | DAO (0.96) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL27941923 | 0.74 | DAO (0.49) | DAOCES1NSD2BCHELIG1 | |
| SCHEMBL4182713 | 0.74 | DAO (0.53) | DAOCES1NSD2BCHELIG1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116158489-B | Method for producing biological fermentation feed by using saccharomyces cerevisiae | 内蒙古海邻科技发展有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-116158489-A | Method for producing biological fermentation feed by using saccharomyces cerevisiae | 内蒙古海邻科技发展有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-102690226-A | Multi-nitrogen substituted isatin derivative and synthetic method of multi-nitrogen substituted isatin derivative | UNIV GUANGDONG TECHNOLOGY | 2012-09-26 | — | — | CN | claimed |
| WO-2007132280-A1 | ISATIN AND ITS DERIVATIVES FOR USE AS A MEDICAMENT | Szegedi Tudományegyetem (HU) | 2007-11-22 | — | — | WO | claimed |
| CN-116158489-B | Method for producing biological fermentation feed by using saccharomyces cerevisiae | 内蒙古海邻科技发展有限公司 | 2023-07-18 | — | — | CN | disclosed |
| CN-116158489-A | Method for producing biological fermentation feed by using saccharomyces cerevisiae | 内蒙古海邻科技发展有限公司 | 2023-05-26 | — | — | CN | disclosed |
| CN-105732476-B | A kind of carbazole isatin type compound and its preparation method and purposes | 吉首大学 | 2017-12-01 | — | — | CN | disclosed |
| EP-2666772-B1 | Synthesis of amines and intermediates for the synthesis thereof | BASF SE (DE) | 2017-03-01 | — | — | EP | disclosed |
| EP-1572647-B1 | SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF | BASF SE (DE) | 2016-09-21 | — | — | EP | disclosed |
| CN-105732476-A | Carbazole-isatin type compound and preparation method and application thereof | 吉首大学 | 2016-07-06 | — | — | CN | disclosed |
| CN-105541808-A | Metronidazole-isatin type compound as well as preparation method and application thereof | UNIV JISHOU | 2016-05-04 | — | — | CN | disclosed |
| CN-1729174-B | The synthesis of amine and the intermediate for the synthesis of amine | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2015-10-21 | — | — | CN | disclosed |
| WO-2005047257-A2 | METHODS AND COMPOSITIONS FOR SELECTIN INHIBITION | WYETH (US) | 2005-05-26 | — | — | WO | disclosed |
| US-20050101568-A1 | Methods and compositions for selectin inhibition | WYETH (US) | 2005-05-12 | — | — | US | disclosed |
| US-20050054712-A1 | Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators | ELI LILLY AND COMPANY | 2005-03-10 | — | — | US | disclosed |
| EP-1487792-A1 | DIHYDROINDOL-2-ONE DERIVATIVES AS STEROID HORMONE NUCLEAR RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2004-12-22 | — | — | EP | disclosed |
| WO-2004056769-A2 | SYNTHESIS OF AMINES AND INTERMEDIATES FOR THE SYNTHESIS THEREOF | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-07-08 | — | — | WO | disclosed |
| WO-2003078394-A1 | DIHYDROINDOL-2-ONE DERIVATIVES AS STEROID HORMONE NUCLEAR RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 2003-09-25 | — | — | WO | disclosed |
| US-4256640-A | ANTIINFLAMMATORY AGENTS, ANALGESICS | SHIONOGI & CO., LTD. (JP) | 1981-03-17 | — | — | US | disclosed |
| US-4110466-A | FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101568-A1 | Methods and compositions for selectin inhibition | SELP, SELE, SELL | DAO 1610/4885CES1 707/4885NSD2 4259/4885 |
| US-20050054712-A1 | Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators | NR3C2, NR5A1, NR5A2 | DAO 4053/4885CES1 1572/4885NSD2 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.